Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.

Harada, N; Hiramatsu, N; Oze, T; Morishita, N; Yamada, R; Hikita, H; Miyazaki, M; Yakushijin, T; Miyagi, T; Yoshida, Y; Tatsumi, T; Kanto, T; Kasahara, A; Oshita, M; Mita, E; Hagiwara, H; Inui, Y; Katayama, K; Tamura, S; Yoshihara, H; Imai, Y; Inoue, A; Hayashi, N; Takehara, T

Harada, N; Hiramatsu, N; Oze, T; Morishita, N; Yamada, R; Hikita, H; Miyazaki, M; Yakushijin, T; Miyagi, T; Yoshida, Y; Tatsumi, T; Kanto, T; Kasahara, A; Oshita, M; Mita, E; Hagiwara, H; Inui, Y; Katayama, K; Tamura, S; Yoshihara, H; Imai, Y; Inoue, A; Hayashi, N; Takehara, T.

Affiliation

Harada N; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.

J Viral Hepat ; 21(5): 357-65, 2014 May.

Article de En | MEDLINE | ID: mdl-24716638

Sujet(s)
Mots clés

Peg-IFN plus ribavirin combination therapy; hepatitis C; hepatocellular carcinoma; normal alanine aminotransferase levels; persistent normal alanine aminotransferase levels

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Polyéthylène glycols / Ribavirine / Interféron alpha / Carcinome hépatocellulaire / Hépatite C chronique / Alanine transaminase Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Viral Hepat Sujet du journal: GASTROENTEROLOGIA Année: 2014 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google